Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1736, Issue 3, 2005, Pages 200-210

  Masuda, Seiko ^a   Murakami, Makoto ^a,b   Ishikawa, Yukio ^c   Ishii, Toshiharu ^c   Kudo, Ichiro ^a  

^a SHOWA UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer; Immunohistochemistry; Infarction; Inflammation; Phospholipase A2

Indexed keywords

PHOSPHOLIPASE A2; PHOSPOLIPASE A2 IIA; PHOSPOLIPASE A2 IID; PHOSPOLIPASE A2 IIE; PHOSPOLIPASE A2 IIF; PHOSPOLIPASE A2 V; PHOSPOLIPASE A2 X; UNCLASSIFIED DRUG;

AGED; ARTICLE; BIODIVERSITY; CELL DAMAGE; CELL DEGENERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY BLOOD VESSEL; ENDOCARDIUM; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME RELEASE; EPITHELIUM CELL; FIBROBLAST; GOBLET CELL; HEART; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; INTESTINE METAPLASIA; KIDNEY; KIDNEY EPITHELIUM; KIDNEY INFARCTION; LIVER; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNET RING CARCINOMA; SMOOTH MUSCLE FIBER; STOMACH; STOMACH CARCINOMA; STOMACH GLAND; SUBMUCOSA; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE; VIRUS HEPATITIS;

AGED; AGED, 80 AND OVER; CARCINOMA, SIGNET RING CELL; CELL LINE, TUMOR; GASTRIC MUCOSA; GENE EXPRESSION; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; INFARCTION; KIDNEY; LIVER; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PHOSPHOLIPASES A; STOMACH NEOPLASMS;

MAMMALIA;

EID: 26444495116     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2005.08.014     Document Type: Article

References (53)

1. 2s Adv. Immunol. 77 2001 163 194
2. 2 enzymes Prostaglandins Other Lipid Mediat. 68-69 2002 3 58
3. 2s and cyclooxygenases in immediate and delayed prostanoid-biosynthetic pathways J. Biol. Chem. 274 1999 3103 3115
4. 2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms J. Biol. Chem. 276 2001 10083 10096
5. 2s J. Biol. Chem. 274 1999 12263 12268
6. 2 that mediates prostaglandin production in mast cells J. Biol. Chem. 272 1997 13591 13596
7. 2 J. Biol. Chem. 277 2002 36479 36488
8. 2 causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I J. Biol. Chem. 275 2000 10077 10084
9. 2 J. Clin. Invest. 102 1998 633 639
10. 2 J. Biol. Chem. 277 2002 5849 5857
11. 2 J. Immunol. 171 2003 995 1000
12. 2 in human tissues Inflammation 17 1993 453 464
13. 2 in the human gastrointestinal tract Lab. Invest. 72 1995 201 208
14. 2 (type II) in human placenta and its possible involvement in normal parturition at term Prostaglandins, Leukot. Essent. Fat. Acids 51 1994 19 26
15. 2 antigen in arthritic synovium Ann. Rheum. Dis. 57 1998 550 558
16. 2 in vascular disease Circ. Res. 89 2001 298 304
17. 2: a mediator between proximal and distal effectors of inflammation Immunol. Today 12 1991 143 146
18. 2 in rodents during inflammation Biochim. Biophys. Acta 1635 2003 37 47
19. 2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells Biochem. J. 387 2005 27 38
20. 2 enzymes are expressed in rheumatoid arthritis and augment prostaglandin production in cultured synovial cells FEBS J. 272 2005 655 672
21. 2 enzymes in male reproductive organs Biochim. Biophys. Acta 1686 2004 61 67
22. 2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis J. Biol. Chem. 277 2002 5061 5073
23. 2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes? Cardiovasc. Res. 60 2003 68 77
24. 2 binds to ischemic myocardium during myocardial infarction in humans Cardiovasc. Res. 53 2002 138 146
25. 2 in myocardial remodelling after infarction Histopathology 47 2005 257 267
26. 2 binds to ischemic flip-flopped cardiomyocytes and subsequently induces cell death Am. J. Physiol.: Heart. Circ. Physiol. 285 2003 H2218 H2224
27. 2-mediated hydrolysis of cardiac phospholipids: the use of molecular and transgenic techniques Mol. Cell. Biochem. 180 1998 65 73
28. 2β, precipitating ventricular tachyarrhythmias in transgenic mice: rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition J. Biol. Chem. 278 2003 22231 22236
29. 2 in rat brain after severe forebrain ischemia and in endotoxic shock Brain Res. 651 1994 353 356
30. 2 induces neuronal cell death via apoptosis Mol. Pharmacol. 61 2002 114 126
31. M.G. Camitta, S.A. Gabel, P. Chulada, J.A. Bradbury, R. Langenbach, D.C. Zeldin, and E. Murphy Cyclooxygenase-1 and-2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning Circulation 104 2001 2453 2458
32. 2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2 J. Biol. Chem. 278 2003 37937 37947
33. 2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells J. Clin. Invest. 92 1993 2516 2523
34. 2 and peroxisome proliferator-activated receptor α activation J. Biol. Chem. 278 2003 29799 29812
35. A.L. Fuson, P. Komlosi, T.M. Unlap, P.D. Bell, and J. Peti-Peterd Immunolocalization of a microsomal prostaglandin E synthase in rabbit kidney Am. J. Physiol. Renal. Physiol. 285 2003 F558 F564
36. 2 gene expression in human hepatoma cells by mediators of the acute phase response J. Biol. Chem. 266 1991 2647 2651
37. 2 expression under hepatocyte injuries by liver diseases J. Gastroenterol. Hepatol. 19 2004 1140 1149
38. M. Casado, N.A. Callejas, J. Rodrigo, X. Zhao, S.K. Dey, L. Bosca, and P. Martin-Sanz Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy FASEB J. 15 2001 2016 2018
39. C.K. Begay, and A.J. Gandolfi Late administration of COX-2 inhibitors minimize hepatic necrosis in chloroform induced liver injury Toxicology 185 2003 79 87
40. D. Rudnick, D.H. Perlmutter, and L.J. Muglia Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration Proc. Natl. Acad. Sci. U. S. A. 98 2001 8885 8890
41. 2 in gastric juice Scand. J. Clin. Lab. Invest. 62 2002 123 128
42. 2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma Am. J. Pathol. 160 2002 667 671
43. 2 expression in rat gastric epithelial cells J. Biol. Chem. 276 2001 21854 21862
44. 2 J. Biol. Chem. 277 2002 19145 19155
45. D. Kamei, M. Murakami, Y. Nakatani, Y. Ishikawa, T. Ishii, and I. Kudo Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis J. Biol. Chem. 278 2003 19396 19405
46. H. Oshima, M. Oshima, K. Inaba, and M.M. Taketo Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice EMBO J. 23 2004 1669 1678
47. 2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia Cell 81 1995 957 966
48. 2 enzymes in mouse stomach Mol. Cell. Biochem. 221 2001 71 77
49. 2 show altered apoptosis and differentiation with Helicobacter felis infection Gastroenterology 114 1998 675 689
50. 2 Helicobacter 9 2004 408 416
51. 2 synthesis in mast cells J. Immunol. 165 2000 4007 4014
52. 2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion Biochem. J. 318 1996 701 710
53. 2 J. Biol. Chem. 280 2005 23203 23214